According to a new technical market research report, GLOBAL MARKET FOR EQUIPMENT USED IN BIOTECHNOLOGY APPLICATIONS (BIO070A) from BCC Research (www.bccresearch.com), the global market value for biotechnology equipment is an estimated $5.5 billion in 2009, but is expected to increase to nearly $7.3 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 5.8%.
The largest segment of the market, imaging, is expected to increase at a 5-year CAGR of 4.9%, from $1.7 billion in 2009 to $2.1 billion in 2014.
The second-largest segment, electrophoresis, is expected to reach a value of $1.2 billion in 2014. The market in 2009 is estimated at more than $966 million. Thus, the 5-year CAGR is projected to be 4.9%.
The segment projected to see the largest growth from 2009 to 2014 is array. It is expected to increase from an estimated $326 million in 2009 to more than $504 million in 2014, for a 5-year CAGR of 9.1%.
The biotechnology equipment market includes the instruments used in separation, purification, and analysis of biomolecules in drug discovery and diagnostics. The market growth of biotechnology instruments has been driven by the growth in drug discovery research, which itself follows the increased demand for newer drugs and therapies worldwide. Moreover, the end of the human genome project has marked revolutions in genomics and proteomics, thus enhancing global research on genes, proteins, and related biomolecules.
The technology market includes chromatography, electrophoresis, sequencers and synthesizers, laboratory automation, an array market, immunoassay, imaging, and mass spectrometry. The end-user market examined in this report includes biopharmaceuticals, academic institutions, government, agriculture, food and beverages, environmental testing labs, gene/protein expression, toxicogenomics, toxicoproteomics, pharmacogenomics, pharmacoproteomics, HTS screening, life science and clinical imaging.
The intended audience for the report would be professionals in pharmaceutical and biotechnology companies, analytical instrument manufacturers, distributors and suppliers, pharmaceutical and biotechnology associations, and contract research organizations.
The largest segment of the market, imaging, is expected to increase at a 5-year CAGR of 4.9%, from $1.7 billion in 2009 to $2.1 billion in 2014.
The second-largest segment, electrophoresis, is expected to reach a value of $1.2 billion in 2014. The market in 2009 is estimated at more than $966 million. Thus, the 5-year CAGR is projected to be 4.9%.
The segment projected to see the largest growth from 2009 to 2014 is array. It is expected to increase from an estimated $326 million in 2009 to more than $504 million in 2014, for a 5-year CAGR of 9.1%.
The biotechnology equipment market includes the instruments used in separation, purification, and analysis of biomolecules in drug discovery and diagnostics. The market growth of biotechnology instruments has been driven by the growth in drug discovery research, which itself follows the increased demand for newer drugs and therapies worldwide. Moreover, the end of the human genome project has marked revolutions in genomics and proteomics, thus enhancing global research on genes, proteins, and related biomolecules.
The technology market includes chromatography, electrophoresis, sequencers and synthesizers, laboratory automation, an array market, immunoassay, imaging, and mass spectrometry. The end-user market examined in this report includes biopharmaceuticals, academic institutions, government, agriculture, food and beverages, environmental testing labs, gene/protein expression, toxicogenomics, toxicoproteomics, pharmacogenomics, pharmacoproteomics, HTS screening, life science and clinical imaging.
The intended audience for the report would be professionals in pharmaceutical and biotechnology companies, analytical instrument manufacturers, distributors and suppliers, pharmaceutical and biotechnology associations, and contract research organizations.
Posts
No comments:
Post a Comment